menu
    • menu

    Company profile for Kira Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kira Pharmaceuticals is working at the forefront of complement drug discovery and developing transformative therapies for people living with immune-mediated diseases. These innovative medicines are designed to more effectively modulate the immune response in diseases and provide new hope for patients around the globe.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kira PharmaceuticalsChina Flag
    Country
    Country
    China
    Address
    Address
    Unit 507, Building A4, Phase I, Bio 218 Xinghu Street, Suzhou Industrial Park ...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kirapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kira-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kira Pharma Presents Updated Ph 2 Data of KP104 in PNH at ASH 2024
    Kira Pharma Presents Updated Ph 2 Data of KP104 in PNH at ASH 2024

    10 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kira-pharmaceuticals-presents-updated-data-of-phase-2-study-of-kp104-in-paroxysmal-nocturnal-hemoglobinuria-pnh-at-american-society-of-hematology-ash-2024-demonstrating-long-term-safety-and-efficacy-302327484.html

    PR NEWSWIRE
    10 Dec 2024
    Share Share
    Kira Presents Long-Term KP104 PNH Phase 2 Results At EHA
    Kira Presents Long-Term KP104 PNH Phase 2 Results At EHA

    16 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kira-pharmaceuticals-to-present-positive-long-term-results-of-kp104-in-phase-2-paroxysmal-nocturnal-hemoglobinuria-pnh-study-at-the-2024-european-hematology-association-eha-hybrid-congress-302147046.html

    PR NEWSWIRE
    16 May 2024
    Share Share
    Kira Presents Positive Results of KP104 Phase 2 Study in Patients with PNH
    Kira Presents Positive Results of KP104 Phase 2 Study in Patients with PNH

    14 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kira-pharmaceuticals-presents-positive-results-of-kp104-phase-2-study-in-complement-naive-patients-with-paroxysmal-nocturnal-hemoglobinuria-pnh-at-the-2023-ash-annual-meeting-302015683.html

    PR NEWSWIRE
    14 Dec 2023
    Share Share
    Kira gets clearance for bifunctional biologic trial in China, Australia
    Kira gets clearance for bifunctional biologic trial in China, Australia

    21 Dec 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/kira-bifunctional-biologic-trial/

    CLINICALTRIALSARENA
    21 Dec 2022
    Share Share
    Kira Announces First Cohort of Patients Dosed in Phase 2 Study of KP104
    Kira Announces First Cohort of Patients Dosed in Phase 2 Study of KP104

    30 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/kira-pharmaceuticals-announces-first-cohort-of-patients-dosed-in-phase-2-study-of-kp104-in-paroxysmal-nocturnal-hemoglobinuria-pnh-301689797.html

    PRNEWSWIRE
    30 Nov 2022
    Share Share
    Kira to Present First-in-Human Clinical Data at Society for Nephrology Kidney
    Kira to Present First-in-Human Clinical Data at Society for Nephrology Kidney

    17 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/kira-pharmaceuticals-to-present-first-in-human-clinical-data-at-american-society-for-nephrology-kidney-week-2022-301650417.html

    PRNEWSWIRE
    17 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search